Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia
Public ClinicalTrials.gov record NCT07365462. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NBI-1065890 in Adult Participants With Tardive Dyskinesia
Study identification
- NCT ID
- NCT07365462
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Neurocrine Biosciences
- Industry
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Interventions
- NBI-1065890 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 5, 2026
- Primary completion
- Jan 31, 2027
- Completion
- Feb 28, 2027
- Last update posted
- Jun 22, 2026
2026 – 2027
United States locations
- U.S. sites
- 18
- U.S. states
- 7
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Neurocrine Clinical Site | Bryant | Arkansas | 72022 | Recruiting |
| Neurocrine Clinical Site | Chino | California | 91710 | Recruiting |
| Neurocrine Clinical Site | Fountain Valley | California | 92708 | Recruiting |
| Neurocrine Clinical Site | Huntington Beach | California | 92648 | Recruiting |
| Neurocrine Clinical Site | Long Beach | California | 90807 | Recruiting |
| Neurocrine Clinical Site | Temecula | California | 92591 | Recruiting |
| Neurocrine Clinical Site | Torrance | California | 90501 | Recruiting |
| Neurocrine Clinical Site | Boca Raton | Florida | 33486 | Recruiting |
| Neurocrine Clinical Site | Bonita Springs | Florida | 34134 | Recruiting |
| Neurocrine Clinical Site | Hialeah | Florida | 33012 | Recruiting |
| Neurocrine Clinical Site | Miami | Florida | 33176 | Recruiting |
| Neurocrine Clinical Site | Orange City | Florida | 32763 | Recruiting |
| Neurocrine Clinical Site | Tampa | Florida | 33629 | Recruiting |
| Neurocrine Clinical Site | Marietta | Georgia | 30060 | Recruiting |
| Neurocrine Clinical Site | Lincoln | Nebraska | 68526 | Recruiting |
| Neurocrine Clinical Site | Beachwood | Ohio | 44122 | Recruiting |
| Neurocrine Clinical Site | Fort Worth | Texas | 76104 | Recruiting |
| Neurocrine Clinical Site | Houston | Texas | 77030 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07365462, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 22, 2026 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07365462 live on ClinicalTrials.gov.